Skip to content

Investigating the effect of remote rehabilitation in physiotherapy treatment of frozen shoulder patients

Effectiveness of augmented tele-rehabilitation based on mobile application to routine physical therapy on pain, range of motion, disability and quality of life in patients with adhesive capsulitis: Randomized controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221030056342N7
Enrollment
48
Registered
2025-12-06
Start date
2025-09-20
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frozen shoulder syndrome. Adhesive capsulitis of shoulder

Interventions

Intervention 1: Individuals in the control group will receive 12 one-hour sessions of treatment as follows: 1. Low-power laser will be applied for 30 seconds to 8 painful points of the shoulder joint

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Limitation in both active and passive range of motion shoulder pain for at least 4 weeks access to a mobile phone capable of installing the tele-rehabilitation app

Exclusion criteria

Exclusion criteria: Bilateral diagnosis of frozen shoulder Frozen shoulder may be secondary to trauma (fracture or dislocation) or secondary to systemic problems (rheumatoid arthritis) cervical radiculopathy history of shoulder surgery Not able to work with the application

Design outcomes

Primary

MeasureTime frame
Score of Shoulder Pain and Disability Index Questionnaire. Timepoint: Immediately before and after treatment. Method of measurement: The SPADI questionnaire is used to assess pain and disability in patients with shoulder disorders. The questionnaire consists of 13 questions in two separate sections: pain (5 items) and disability (8 items). The total score ranges from 0 to 100, with higher scores indicating greater pain and disability.

Secondary

MeasureTime frame
Score of Visual Analogue Scale. Timepoint: Immediately before and after treatment. Method of measurement: In this scale, there is a 10 cm horizontal line segment, the left end of which corresponds to the absence of pain and the other end corresponds to the most severe pain that the person experiences. The distance between the left side and the marker is calculated in centimeters and is calculated as the intensity of the pain.;Range of motion. Timepoint: Immediately before and after treatment. Method of measurement: To examine the range of motion of the shoulder joint, a goniometer will be used in the supine position based on Kelley guidelines.;Score of 12 Item Short Form Survey Quality of Life Questionnaire. Timepoint: Immediately before and after treatment. Method of measurement: It is a 12-question questionnaire and a shorter version of the 36SF- which is divided into two main sections: physical and mental health. A higher score indicates a better quality of life and a lower score indicates a lower quality of life.;Quick Disabilities of Arm, Shoulder, and Hand Questionnaire. Timepoint: Immediately before and after treatment. Method of measurement: It is an 11-question questionnaire that assesses the degree of disability in daily activities, limitations in work and recreational activities, the degree of pain, and the psychological impact of the condition. Scores on this questionnaire range from 0 to 100. Higher scores indicate greater disability, and lower scores indicate less disability.;Score of Global Rating Scale. Timepoint: Immediately before and after treatment. Method of measurement: The scale is 11 points, ranging from -5 (much worse) to 0 (no change) and +5 (much better). The patient is asked to rate the change in the shoulder following the treatment plan.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfsaneh Zeinalzadeh

Mashhad University of Medical Sciences

sps.Dean@mums.ac.ir+98 51 3884 6710

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026